Walleye Capital LLC Raises Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Walleye Capital LLC increased its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 43.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,507 shares of the company’s stock after purchasing an additional 13,412 shares during the quarter. Walleye Capital LLC’s holdings in Definitive Healthcare were worth $199,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Massachusetts Financial Services Co. MA boosted its holdings in shares of Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after buying an additional 1,626,813 shares in the last quarter. 272 Capital LP purchased a new stake in shares of Definitive Healthcare in the 2nd quarter worth approximately $3,480,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Definitive Healthcare in the third quarter worth $512,000. Marshall Wace LLP bought a new stake in Definitive Healthcare in the second quarter worth $1,535,000. Finally, Millennium Management LLC bought a new stake in Definitive Healthcare in the second quarter worth $9,283,000. Institutional investors own 98.67% of the company’s stock.

Insider Activity

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.84% of the stock is owned by corporate insiders.

Definitive Healthcare Price Performance

NASDAQ DH opened at $4.71 on Thursday. The stock has a 50-day moving average of $4.40 and a 200 day moving average of $4.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market capitalization of $544.11 million, a price-to-earnings ratio of -1.52, a PEG ratio of 3.44 and a beta of 1.39. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on DH shares. BTIG Research started coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.